Beijing Tianheng Pharmaceutical Research Institute is a high-tech enterprise specializing in the research and development of new drugs, with research areas covering chemical drugs, traditional Chinese medicine, and novel formulations. Over the past nine years of new drug research, it has obtained more than 100 new drug certificates, involving various dosage forms such as active pharmaceutical ingredients, solid preparations, injections, and topical preparations, accumulating substantial experience in the research and development of new drugs.

To meet new market demands, the institute began research on innovative drugs with independent intellectual property rights several years ago. Currently, several projects have made significant progress and are in the final stages of preclinical research.

The institute maintains excellent cooperation with numerous domestic and international manufacturers in areas such as new drug research and development, generic drug contract research, clinical research agency services, and import drug registration agency services.

The institute employs a total of 60 scientific researchers, with an average age of 30. Over two-thirds of the researchers hold master's degrees or higher. Substantial experience, rigorous scientific management, and a high level of professionalism have positioned the institute as a leader in the domestic industry.